Vistagen TherapeuticsVTGN
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 58 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings, up 7 from Q2 2025. 14 opened new positions and 7 sold out. The largest holders were Janus Henderson Group PLC ($14.7M), Orbimed Advisors LLC ($10.9M) and TCG Crossover Management, LLC ($9.5M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Vistagen Therapeutics Inc.
- CUSIP
- 92840H400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $29.3M |
| Exits | 7 | $1.1M |
All 13F filers, Q2 2025 → Q3 2025: 9,443,950 shares bought and 1,571,742 shares sold, net +7,872,208 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 58 holders
| Janus Henderson Group PLC | 0.01% | New | 4,165,767 | $14.7M |
| Orbimed Advisors LLC | 0.26% | New | 3,060,000 | $10.9M |
| TCG Crossover Management, LLC | 0.47% | No change | 2,676,580 | $9.5M |
| Stempoint Capital LP | 1.56% | Add +3.1% | 2,488,685 | $7.7M |
| Nantahala Capital Management, LLC | 0.43% | No change | 1,978,492 | $7.0M |
| Vanguard Group Inc. | 0.00% | Reduce -4.1% | 1,687,735 | $6.0M |
| Commodore Capital LP | 0.27% | No change | 1,575,000 | $5.6M |
| Ikarian Capital, LLC | 0.45% | Add +3.2% | 620,869 | $2.2M |
| Soleus Capital Management, L.P. | 0.10% | New | 550,000 | $2.0M |
| BlackRock, Inc. | 0.00% | Add +1.5% | 423,128 | $1.5M |
| Renaissance Technologies | 0.00% | Add +942.0% | 422,012 | $1.5M |
| Diadema Partners LP | 0.86% | Reduce -13.4% | 349,789 | $1.2M |
| Jane Street Group, LLC | 0.00% | Add +218.4% | 302,683 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +9.3% | 298,280 | $1.1M |
| Two Sigma Investments, LP | 0.00% | Add +223.5% | 289,409 | $1.0M |
| JPMorgan Chase & Co. | 0.00% | Reduce -63.7% | 271,825 | $965K |
| Almitas Capital LLC | 0.21% | No change | 261,399 | $928K |
| AdvisorShares Investments LLC | 0.12% | Add +1.9% | 206,998 | $735K |
| Boothbay Fund Management, LLC | 0.02% | Add +10.8% | 197,024 | $699K |
| Two Sigma Advisers, LP | 0.00% | Add +507.9% | 157,032 | $557K |
| BML Capital Management, LLC | 0.49% | No change | 150,000 | $533K |
| Citadel Advisors | 0.00% | New | 122,062 | $433K |
| ADAR1 Capital Management, LLC | 0.04% | Reduce -73.1% | 113,062 | $401K |
| State Street Corp. | 0.00% | No change | 96,858 | $344K |
| Susquehanna International Group, LLP | 0.00% | Reduce -25.8% | 85,594 | $304K |
| Persistent Asset Partners Ltd | 0.19% | Reduce -13.3% | 75,319 | $267K |
| XTX Topco Ltd | 0.01% | New | 69,712 | $247K |
| Dimensional Fund Advisors LP | 0.00% | Add +56.9% | 68,017 | $241K |
| Walleye Capital LLC | 0.00% | New | 67,770 | $241K |
| Goldman Sachs Group Inc. | 0.00% | New | 60,152 | $214K |
| Northern Trust Corp. | 0.00% | No change | 48,093 | $171K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 43,953 | $156K |
| Occudo Quantitative Strategies LP | 0.02% | New | 42,704 | $152K |
| American Century Companies Inc. | 0.00% | Add +32.2% | 41,072 | $146K |
| Bank of America Corp. | 0.00% | Add +926.0% | 34,657 | $123K |
| Gsa Capital Partners LLP | 0.01% | New | 31,486 | $112K |
| Group One Trading LLC | 0.00% | Add +305.0% | 28,928 | $103K |
| Morgan Stanley | 0.00% | Add +126.7% | 27,534 | $98K |
| UBS Group AG | 0.00% | Add +12.5% | 25,667 | $91K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 23,302 | $83K |
| HighTower Advisors, LLC | 0.00% | No change | 20,828 | $74K |
| Millennium Management | 0.00% | New | 20,676 | $73K |
| Kestra Advisory Services, LLC | 0.00% | No change | 20,033 | $71K |
| Quadrature Capital Ltd | 0.00% | New | 15,752 | $56K |
| Blair William & Co. | 0.00% | Reduce -85.4% | 12,573 | $45K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 10,883 | $39K |
| Truvestments Capital LLC | 0.01% | Add +21.0% | 8,655 | $31K |
| FNY Investment Advisers, LLC | 0.01% | New | 6,000 | $21K |
| Osaic Holdings, Inc. | 0.00% | Reduce -8.9% | 4,093 | $14K |
| Citigroup Inc. | 0.00% | Reduce -2.4% | 3,453 | $12K |
| Performa Ltd (US), LLC | 0.00% | No change | 1,000 | $4K |
| Cwm, LLC | 0.00% | No change | 582 | $2K |
| MAI Capital Management | 0.00% | No change | 526 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +0.7% | 290 | $1K |
| Jones Financial Companies LLLP | 0.00% | No change | 114 | $402 |
| BNP Paribas Financial Markets | 0.00% | Reduce -88.3% | 56 | $199 |
| Fairman Group, LLC | 0.00% | No change | 29 | $103 |
| Barclays PLC | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.